Authors: MIROCHNICK M CAPPARELLI E DANKNER W SPERLING RS VANDYKE R SPECTOR SA

Citation: M. Mirochnick et al., ZIDOVUDINE PHARMACOKINETICS IN PREMATURE-INFANTS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 808-812

Authors: MUELLER AJ JIAN G BANKER AS RAHHAL FM CAPPARELLI E FREEMAN WR

Citation: Aj. Mueller et al., THE EFFECT OF DEEP POSTERIOR SUBTENON INJECTION OF CORTICOSTEROIDS ONINTRAOCULAR-PRESSURE, American journal of ophthalmology, 125(2), 1998, pp. 158-163

Authors: BAKSHI SS BRITTO P CAPPARELLI E MOFENSON L FOWLER MG RASHEED S SCHOENFELD D ZIMMER B FRANK Y YOGEV R JIMENEZ E SALGO M BOONE G PAHWA SG

Citation: Ss. Bakshi et al., EVALUATION OF PHARMACOKINETICS, SAFETY, TOLERANCE, AND ACTIVITY OF COMBINATION OF ZALCITABINE AND ZIDOVUDINE IN STABLE, ZIDOVUDINE-TREATED PEDIATRIC-PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 175(5), 1997, pp. 1039-1050

Authors: YUEN GJ DRUSANO GL FLETCHER C CAPPARELLI E CONNOR JD LALEZARI JP DREW L FOLLANSBEE S BUSCH D JACOBSON M SPECTOR SA SQUIRES K BUHLES W

Citation: Gj. Yuen et al., POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2350-2352

Authors: BURNS JC GLODE MP CAPPARELLI E BROWN JA NEWBURGER JW

Citation: Jc. Burns et al., INTRAVENOUS GAMMA-GLOBULIN (IVIG) IN THE TREATMENT OF KAWASAKI SYNDROME (KS) - ARE ALL BRANDS EQUAL, Pediatric research, 37(4), 1995, pp. 171-171

Authors: AREVALO JF GONZALEZ C KIRSCH LS GARCIA R QUICENO JI CONNOR JD GAMBERTOGLIO J CAPPARELLI E SHERWOOD CH BERGERONLYNN G FREEMAN WR

Citation: Jf. Arevalo et al., INTRAVITREAL ANTIVIRAL DRUG CONCENTRATION AFTER INTRAVENOUS GANCICLOVIR AND FOSCARNET IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENTS WITH CYTOMEGALOVIRUS RETINITIS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1892-1892